Talphera Inc

TLPHNASDAQ · USD
1.16USD+0.03 (+2.66%)
159

Talphera Inc (TLPH) Covered Calls

No qualifying covered call setups were found for TLPH in the prior session.

Read more

Running TLPH covered calls helps you generate consistent income from Talphera Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Talphera Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TLPH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TLPH stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TLPH covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Talphera Inc covered call is worth writing.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.

The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.

Income-focused investors, long-term TLPH holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TLPH covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Talphera Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile87.70% Elevated
  • Market cap (M$)59
  • 52 weeks high-28.03%
  • 52 weeks low63.77%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$3.12
    168.97% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-11
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.26
  • EPS growth next 5 years28.04%

As of October 2, 2026

No illustrative rows to display.

As of October 2, 2026

Sell covered calls with the data behind you

Find the best TLPH covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial